ANXIETY: FAST FACTS AND SKILLS FOR THE PRIMARY CARE PHYSICIAN

Similar documents
MEDICATION ALGORITHM FOR ANXIETY DISORDERS

Treatment of Anxiety (without benzos)

WHEN AND HOW TO USE BENZODIAZEPINES IN TREATING ANXIETY: AM I WITHHOLDING TREATMENT IF I DON'T USE BENZODIAZEPINES?

CBT FOR ANXIETY (CBT-A): WHAT CAN I DO WITH MY PATIENT INSTEAD OF GIVING THEM A PRN BENZODIAZEPINE

Panic disorder is a chronic and recurrent illness associated

Lori Higa, BSN, RN-BC. Anxiety

ANXIETY: SCREENING, DIFFERENTIAL DIAGNOSIS, TREATMENT MONITORING

WHICH BIPOLAR MEDS TO USE IN PRIMARY CARE?

Treating Anxiety Disorders. Adil Virani, BSc (Pharm), Pharm D, FCSHP

How to Manage Anxiety

MICHELE BEDARD-GILLIGAN, PH.D. ASSISTANT PROFESSOR DEPARTMENT OF PSYCHIATRY AND BEHAVIORAL SCIENCES UNIVERSITY OF WASHINGTON

Medication for Anxiety and Depression. PJ Cowen Department of Psychiatry, University of Oxford

Anxiety Disorders. Fear & Anxiety. Anxiety Disorder? 26/5/2014. J. H. Atkinson, M.D. Fear. Anxiety. An anxiety disorder is present when

Anxiety Disorders.

Where to from Here? Evidence-Based Strategies for Treatment of Refractory Depression

Psychiatric Consultant Role in Collaborative Care Sept 12, 2013

Disclosure Information

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers

Depression & Anxiety in Adolescents

Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment

ANXIETY DISORDERS IN THE ELDERLY IMPACT OF LATE-LIFE ANXIETY CHANGES IN DSM-5 THE COSTS 6/4/2015 LATE-LIFE ANXIETY TOPICS TO BE COVERED

"When I die, I hope it's in a meeting. The transition from life to death will be barely perceptible." Richard Balon

OCD Service: Back to Clinical Practice. August 7, 2015

Session 3: Help Me, Doc - I ve Got High Anxiety! Learning Objectives

Fortunately, panic disorder is one of the most treatable anxiety disorders. The illness can be controlled with medication and focused psychotherapy.

Document Title Pharmacological Management of Generalised Anxiety Disorder

Integrated Care for Depression, Anxiety and PTSD. Introduction: Overview of Clinical Roles and Ideas

Managing Anxiety Disorder in Primary Care

Start Low, Go Slow but Treat to Target

Presentation is Being Recorded

9/20/2011. Integrated Care for Depression & Anxiety: Psychotropic Medication Management for PCPs. Presentation is Being Recorded

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX

Medications for Borderline Personality Disorder

Mixing and Matching: Layering Medications as Family Physicians

Basics of Benzodiazepine Use Disorder. DATE: June 12, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR

Kari A. Stephens, PhD & Wayne Bentham, MD Psychiatry & Behavioral Sciences University of Washington. Approach for doing differential diagnosis of PTSD

Basics of Benzodiazepine Use Disorder. DATE: March 20, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR

Anxiety Disorders: First aid and when to refer on

BIPOLAR DISORDERS DIAGNOSTIC AND TREATMENT ISSUES RICHARD RIES MD

Basics of Benzodiazepine Use Disorder. DATE: October 3, 2017 PRESENTED BY: Melissa B. Weimer, DO, MCR

Guideline for the Diagnosis and Management of Generalized Anxiety Disorder for Primary Care Physicians

Mental illness A Broad Overview. Dr H Pathmanandam March 2017

Disclosures. Objectives. Symptoms of fear. The Fifteen Minute Hour: Psychotherapy & Medications for Anxiety Management in Primary Care 4/5/18

Anxiolytics and anxiety disorders. MUDr. Vítězslav Pálenský Dept. of Psychiatry, Masaryk University, Brno

P A N A N X I E T Y C

Clinical Significance of Anxiety in Depressed Patients Selecting an Antidepressant

for anxious and avoidant behaviors.

ANTIPSYCHOTIC POLYPHARMACY

Psychiatry curbside: Answers to a primary care doctor s top mental health questions

OBJECTIVES. 1. Become familiar with common classes of psychotropic medications, indications for their use, and side effects.

Dr. Catherine Mancini and Laura Mishko

Antidepressant Medication Therapy in Primary Care July 25, 2013

Disclosures. Overview of Workshop. Objectives. Medical Care of Vulnerable and Underserved Populations: Advanced Cases in Anxiety and Depression

Non-A, non-b=hcv; IFN/RBV; DSM-5/Ham-D, OLT; SSRI, P450

Management Of Depression And Anxiety

Anxiety. Definition. Sometimes anxiety results from a medical condition that needs treatment. Whatever form of anxiety you have, treatment can help.

Highs and Lows. Anxiety and Depression

Is Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A

Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation

DRUGS USED IN THE TREATMENT OF ADDICTION JOSEPH A. TRONCALE, MD FASAM RETREAT PREMIERE ADDICTION TREATMENT CENTERS

Is Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A

Short Clinical Guidelines: General Anxiety Disorder (GAD)

Optimal Treatment of Anxiety Disorders

Challenges in identifying and treating bipolar depression: a guide

foreword general general Six Persimmons 六柿圖 other modalities of treatments by evidence or impression? anxiety disorders drugs benzodiazepines

Disclosure Statement. A Rational Approach to Psychopharmacology. Goals 10/28/2013

Case #1. Case #1. Case #1. Discussion. DSM IV Overview of PD. Psychopharmacology of Panic Disorder and Generalized Anxiety Disorder 09/03/2012

ANXIETY IN THE ELDERLY Synergize March 2, Dallas Seitz, MD PhD FRCPC Department of Psychiatry, Queen s University Providence Care MHS

GERIATRIC MENTAL HEALTH AND MEDICATION TREATMENT

For: NEON Primary Healthcare Providers By: Michelle Romero, DO June 2013

Major Depressive Disorder (MDD) in Children under Age 6

PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS. Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA

Clinical Update on Management of Depression and Anxiety in the Primary Care Setting. Objectives: Why Is This Important?

Principles in Action Case Example

COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications*

the Worry Over Anxiety Disorders in All the Wrong Places How do you detect anxiety disorders? In this article: By Sagar V.

Mental Health and Stress

EARLY ONSET SCHIZOPHRENIA

Primary Care Psychopharmacology for Anxiety Disorders. Holly Ellison, RN, MSN, PMHNP-BC Board Certified Psychiatric Mental Health Nurse Practitioner

Augmentation and Combination Strategies in Antidepressants treatment of Depression

Best Practices in Prescribing Benzodiazepines. Michael Carlisle, DO Medical Director University Hospitals Geauga Medical Center

Medication Management. Dr Ajith Weeraman MBBS, MD (Psychiatry), FRANZCP Consultant Psychiatrist Epworth Clinic Camberwell 14 th March 2015

Medication management of anxiety & depression. Dr Katie Simpson GP Mental health lead East Berks CCG

Panic Disorder with or without Agoraphobia

Depression Assessment and Management. John Kern MD Clinical Professor University of Washington

Anxiolytics. What s new? Lindsey Sinclair

Answer Key for Case Studies. Grading for each case study. All Case Studies

Psychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis

UPDATE ON PTSD PHARMACOTHERAPY: IS THERE ANYTHING THAT WORKS BETTER THAN SSRIS FOR PTSD?

Resident Rotation: Collaborative Care Consultation Psychiatry

Mentoring Session: Participant Cases

Disclosures. Learning Objectives. Psychopharmacology of Pediatric Anxiety and Depression 5/4/2017

2/23/18. Age of Anxiety: Transforming Qualms into Calm. Disclosures. Objectives. I have nothing to disclose

Post-Traumatic Stress Disorder

Depression in Late Life

AN OVERVIEW OF ANXIETY

Manual of Clinical Psychopharmacology

FROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD OF ANXIETY

GENERALIZED ANXIETY DISORDER (GAD) PRACTICE PRINCIPLE FOR PRIMARY CARE: ADULTS 18 AND OLDER

Anxiety Disorders. Dr Simon Christopherson Dr Alison Macrae

Transcription:

UW PACC Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences ANXIETY: FAST FACTS AND SKILLS FOR THE PRIMARY CARE PHYSICIAN RYAN KIMMEL, MD MEDICAL DIRECTOR HOSPITAL PSYCHIATRY UNIVERSITY OF WASHINGTON MEDICAL CENTER UW PACC 2017 University of Washington

GENERAL DISCLOSURES The University of Washington School of Medicine also gratefully acknowledges receipt of educational grant support for this activity from the Washington State Legislature through the Safety-Net Hospital Assessment, working to expand access to psychiatric services throughout Washington State. UW PACC 2017 University of Washington

SPEAKER DISCLOSURES - None UW PACC 2017 University of Washington

One Minute Anxiety Diagnosis: Have you Had Sudden unexpected anxiety or physical symptoms when no one around (Panic) Worry, tense, anxious more days than not for 6 months (Generalized Anxiety-GAD) Anxiety and/or avoidance in social situations (Social Anxiety Disorder/Social Phobia) Recurrent intrusive recollections of trauma or avoidance of trauma reminders (PTSD) Means-Christenson et al: General Hospital Psychiatry 28 (2006) 108 118

Education and Skills: A Context for Pharmacotherapy Medication will work better in a self-activated patient. - Just throwing meds at the problem will not work. Provide explanations that de-mystify and depathologize. - Anxiety is not one thing but three things (physical feeling, thought, and behavior) - Anxiety is a normal reaction that has just become triggered at times when it is not really needed. - It is a product of genetic make-up AND learning AND habit. It is not brain damage or a tumor.

Breathing/ Meditation/ Relaxation Education: Anxiety Cycle Correct Cognitive Errors - CBT Physical symptoms (e.g., sweaty, shaking) Thoughts of : dying, going crazy, losing control; danger and catastrophe; being negatively judged by others Avoidance and escape behaviors Exposure and Activation

Prior to Initiating Treatment Assess severity of anxiety so you can monitor the effects of treatment! Use GAD-7 at each visit In motivated patients, use daily diaries with 0-10 scales for individual anxiety symptoms Use the PHQ-9 for depression Work on motivation for CBT and not just medication.

Spitzer, R. L. et al. Arch Intern Med 2006;166:1092-1097. Copyright restrictions may apply.

Anxiety Disorders: Initial Medication Choice SSRIs and Venlafaxine XR: - Equally effective for PD, GAD, SAD, PTSD - SSRI better tolerated! Don t assume prior medication trials were ineffective unless optimal dose (top doses) and durations (10-13 weeks) were reached

Titration of Initial Medication Treatment Start at low dose and titrate gradually to therapeutic dose over 2-4 wks Initial response to antidepressant (>25% change) usually occurs within 4-6 weeks Partial responders after 4-6 weeks should be titrated to higher doses if tolerated If no response after 4-6 weeks at therapeutic dose, but med is well tolerated AND patient is willing, titrate to maximum dose over another 4-6 weeks Try to get to maximum doses AND durations!

Case #1 Sydney is a 21 year-old UW student. She notes she has always been a "worrier. She feels exhausted all the time because she lies in bed worrying for hours. She notes irritability and poor concentration. She notes that her sister was diagnosed with GAD a couple years ago and, after a number of medication trials, had had good success with venlafaxine. Syndey s PCP diagnoses her with GAD and titrates venlafaxine up to 300mg over the next 4 weeks. After six weeks, Sydney feels her schoolwork is going a little better, but is worried that her worrying will never be able to relax like other people. How long should Sydney s provider wait before switching antidepressants?

GAD Response Increases Over Time - Wait Before Changing! 40 30 20 10 0 Remission Rate (%) 50 Remission HAM-A 7 Placebo Venlafaxine XR * (N=767) * * Wk 1 Wk 2 Wk 4 Wk 6 Wk 8 Mo 3 Mo 5 Mo 6 Time * * * *p<0.001 vs. placebo; p<0.01 vs. placebo; Montgomery SA, Sheehan DV, Meoni P, et al. J Psychiatr Res. 2002(July-Aug);36(4):209-217

Anxiolytic Pharmacotherapy: Medications with minimal utility Bupropion Ineffective for ALL disorders! Buspirone only works for GAD Beta-blockers only work for Performance Anxiety (GAD data very equivocal) Antihistamines only work for GAD, and usually have problematic side effects TCAs have more side effects than SSRIs, are lethal on overdose, and don t work for Social Anxiety

Case #2 A 48yo woman notes panic attacks for several decades, though they previously occurred only a couple times a year. For the last two months, however, she notes symptoms consistent with a major depressive episode and notes her panic attacks now occur daily. Though excruciating, the attacks last only 20 minutes. She has no history of psychiatric medication trials, but has recently started working with a therapist. She asks her primary care provider for a medication to take when she is experiencing a panic attack.

When Would I Want to Choose a Benzodiazepine? If history of non-response to two different antidepressant classes and a combination of SRI and mirtazapine (or gabapentin?) and therapy If severe medical illness or other contraindications to using other antidepressants If patient is Bipolar (for some, SRIs are destabilizing) If patient does not have a prior history of substance abuse problems If concomitant depression already being treated If diagnosis is NOT PTSD (may worsen response rate) Best to use in combination with an AD

Info Needed to Assess and Manage Current Benzo Use Regular schedule (daily prn is regular, but bad) Duration of use History of substance use/abuse Diagnosis (most justified for panic and Social Anxiety; less for GAD; no utility for PTSD or MDD) GAD is the least definitive Anxiety Diagnosis--could be: occult substance abuse, personality disorder, anxious depression, unrecognized bipolar illness, or even ADHD

Managing The Patient Who Is Already On A Benzo When You Meet Them Patient needs to commit to work with exclusively with you (check Rx monitoring program) and must have no substance abuse history (UTOX?) Note your aim is for a gradual reduction in dose Say reduction will be done AFTER other medication or behavioral treatment is initiated Give plan for initiation of reduction as within 2 months, and hopefully don t need med at all after 6 mo. NO PRN USE!! Regular schedules

Atypical Neuroleptics: High Risk Limited Gain Limited RCT evidence (but still better than anticonvulsant data) Strongest data support adjunctive use, added to SSRI, in OCD (Olanzapine, Risperidone, Quetiapine) Adverse effects on lipids, glucose and weight much better established than clinical benefits! Adjunctive use is third line option in disabling, resistant anxiety In patients without a history of substance use disorders, benzos may be safer overall than antipsychotics, and with better evidence for efficacy!